Paclitaxel Concept

subject area of

• A Comparison of Two Prophylactic Regimens for Hypersensitivity Reactions to Paclitaxel  Journal Articles
• A Division of Labor between YAP and TAZ in Non–Small Cell Lung Cancer  Journal Articles
• A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer  Journal Articles
• A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer  Journal Articles
• A comparison of the costs of paclitaxel and best supportive care in stage IV non-small-cell lung cancer.  Journal Articles
• A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab  Journal Articles
• A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial  Journal Articles
• A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer  Journal Articles
• A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.  Journal Articles
• A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study  Journal Articles
• A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.  Journal Articles
• A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer  Journal Articles
• Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel  Journal Articles
• Antiangiogenic Therapies in Non-Small-Cell Lung Cancer  Journal Articles
• Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimens  Journal Articles
• Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.  Journal Articles
• Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial  Journal Articles
• Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients  Journal Articles
• Comparison of one-year clinical outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice  Journal Articles
• Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid)  Journal Articles
• Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non–Small Cell Lung Cancer in China  Journal Articles
• Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer  Journal Articles
• Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer  Journal Articles
• Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: an Ontario perspective.  Journal Articles
• Effect of docetaxel (taxotere) on expression of radiation-induced lethal mutations in human cell lines  Journal Articles
• Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer  Journal Articles
• Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer  Journal Articles
• First line therapy with paclitaxel (Taxol®) and pegylated liposomal doxorubicin (Caelyx®) in patients with metastatic breast cancer: a multicentre phase II study  Journal Articles
• First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)—a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG  Journal Articles
• Flavopiridol Sensitivity of Cancer Cells Isolated from Ascites and Pleural Fluids  Journal Articles
• Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer  Journal Articles
• Getting to the heart of the problem: a case report on the use of emergency department ultrasonography in a patient with shortness of breath.  Journal Articles
• IVUS-guided management of late stent malaposition with peri-stent restenosis with coronary artery aneurysm following drug-eluting stent implantation (paxlitaxel-eluting stent).  Journal Articles
• Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial Design  Journal Articles
• Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial)  Journal Articles
• Induction of Apoptotic Cell Death Specifically in Rat and Human Cancer Cells by Pancratistatin  Journal Articles
• Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer  Journal Articles
• Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells  Journal Articles
• Interrelationships of endoplasmic reticulum, mitochondria, intermediate filaments, and microtubules—a quadruple fluorescence labeling study  Journal Articles
• Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cells  Journal Articles
• Long-Term Follow-Up of Percutaneous Coronary Intervention With Paclitaxel-Eluting Balloon Catheter  Journal Articles
• Long-term benefit using DES in STEMI patients.  Journal Articles
• Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: A Canadian experience  Journal Articles
• Long‐Term Results After Drug‐Eluting Versus Bare‐Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial  Journal Articles
• Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes  Conferences
• Malignant pleural mesothelioma: a phase II trial with docetaxel  Journal Articles
• Method to Our Madness or Madness in Our Methods? Pitfalls in Trial Methodology  Journal Articles
• Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis  Journal Articles
• Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study  Journal Articles
• Naturally occurring resistance of bone marrow mononuclear and metastatic cancer cells to anticancer agents  Journal Articles
• Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review  Journal Articles
• New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities  Journal Articles
• Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial  Journal Articles
• Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study  Journal Articles
• PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat  Journal Articles
• Paclitaxel Versus Sirolimus Stents in Diabetic and Nondiabetic Patients  Journal Articles
• Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial  Journal Articles
• Paclitaxel and cisplatin as intravesical agents against non‐muscle‐invasive bladder cancer  Journal Articles
• Paclitaxel plus hydroxyurea as second line therapy for non-small cell lung cancer  Journal Articles
• Pancratistatin: A natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis  Journal Articles
• Patients’ Preferences for Therapy in Advanced Epithelial Ovarian Cancer: Development, Testing, and Application of a Bedside Decision Instrument  Journal Articles
• Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity  Journal Articles
• Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel  Journal Articles
• Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer  Journal Articles
• Phase I Trial of the Matrix Metalloproteinase Inhibitor Marimastat Combined with Carboplatin and Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer  Journal Articles
• Phase I and Pharmacokinetic Study of Daily Oral AZD2171, an Inhibitor of Vascular Endothelial Growth Factor Tyrosine Kinases, in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non–Small-Cell Lung Cancer: The National Cancer Institute of Canada Clinical Trials Group  Journal Articles
• Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer  Journal Articles
• Primary and Rescue Percutaneous Coronary Intervention With Paclitaxel-Eluting Stent Implantation in ST-Elevation Myocardial Infarction  Journal Articles
• Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer  Journal Articles
• Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29  Journal Articles
• Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer  Journal Articles
• Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18  Journal Articles
• Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer  Journal Articles
• Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study  Journal Articles
• Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis  Journal Articles
• Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization  Journal Articles
• Salvage surgery after induction chemotherapy with paclitaxel/cisplatin and primary radiotherapy for advanced laryngeal and hypopharyngeal carcinomas  Journal Articles
• Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events  Journal Articles
• Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma  Journal Articles
• Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.  Journal Articles
• Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants  Journal Articles
• Symptom clusters using the Brief Pain Inventory in patients with breast cancer  Journal Articles
• Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline  Journal Articles
• Taxol (paclitaxel) involution of articular cartilage destruction in collagen induced arthritis: an ultrastructural demonstration of an increased superficial chondroprotective layer.  Journal Articles
• Taxol Involution of Collagen-Induced Arthritis: Ultrastructural Correlation with the Inhibition of Synovitis and Neovascularization  Journal Articles
• Taxol encapsulation in poly(epsilon-caprolactone) microspheres  Journal Articles
• Taxol resistant mutants of Chinese hamster ovary cells: Genetic biochemical, and cross‐resistance studies  Journal Articles
• Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)  Journal Articles
• The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma  Journal Articles
• The Thrombospondin-1 Mimetic ABT-510 Increases the Uptake and Effectiveness of Cisplatin and Paclitaxel in a Mouse Model of Epithelial Ovarian Cancer  Journal Articles
• The chemosensitizing potential of GF120918 is independent of the magnitude of P-glycoprotein-mediated resistance to conventional chemotherapeutic agents in a small cell lung cancer line.  Journal Articles
• Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline  Journal Articles
• Treatment of Restenosis with a Paclitaxel-Coated Balloon Catheter  Journal Articles
• Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24  Journal Articles
• Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer  Journal Articles
• Twenty-Twenty Hindsight: An Adjuvant Breast Cancer Trial Through the Retrospectoscope  Journal Articles